Puyi Biotechnology Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2012

Location

Shanghai China

Primary Industry

Medical Devices & Equipment

About

Based in Shanghai, China and established in 2012, Puyi Biotechnology is a biotechnology company that engages in the research and development, production and sale of interventional treatment devices. In 2017, The fully degradable sinus drug stent system developed by the company obtained a product registration certificate from the National Food and Drug Administration. The company's products include sinus drug stent system, nasal septum stent, eustachian tube balloon, olfactory reagent, etc. Besides, the company has also developed cervical balloons, biodegradable ureteral stents, hyaluronic acid and other products in the fields of gynecology, urology, and cosmetic medicine. In 2021, the company plans to list on the Hong Kong Stock Exchange.

Current Investors

Legend Capital, NLVC, Zhenghe Huitong Fund Management

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment, Medical Equipment Distributors

Website

www.puyibio.com

Verticals

HealthTech

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.